Molecular dermatology research and development innovator DermaGenoma Inc has released the HerpesDX genetic test for frequent Genital herpes. The new screening test will help doctors assess patients risk for developing frequent Genital Herpes (HSV-2) outbreaks.
Read MoreCarolina Liquid Chemistries, GlycoMark Partner for New Diabetes Management Test Carolina Liquid Chemistries Corp will market the GlycoMark® blood test as one of a complete range of diabetes assays for the BioLis 24i benchtop chemistry analy
Read More
Smart selection and utilization play a growing role in POCT strategies
Read MoreAsuragen Inc has announced an agreement to develop and manufacture RNA Control Kits for Affymetrix.
Read MoreQIAGEN NV and Celera Corp announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN’s ResPlex II assay for detection of respiratory pathogens.
Read More